Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 4
2011 2
2012 1
2014 1
2015 2
2016 2
2017 9
2018 12
2019 13
2020 9
2021 9
2022 11
2023 16
2024 13
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean vrancken peeters mjtfd (96 results)?
A clinical perspective on oncoplastic breast conserving surgery.
Heeling E, van Hemert AKE, Vrancken Peeters MTFD. Heeling E, et al. Among authors: vrancken peeters mtfd. Transl Breast Cancer Res. 2023 Sep 28;4:29. doi: 10.21037/tbcr-23-40. eCollection 2023. Transl Breast Cancer Res. 2023. PMID: 38751480 Free PMC article. Review.
Missed opportunities and challenges for surgical breast cancer research in the era of personalized cancer treatment.
Rubio IT, Kontos M, Vrancken-Peeters M, Rouzier R, Skandarajah AR, Galimberti V, Kroman N, Caballero C, Ohno S; BIG Task Force Surgical Trials. Rubio IT, et al. Among authors: vrancken peeters m. Eur J Surg Oncol. 2020 Apr;46(4 Pt A):501-503. doi: 10.1016/j.ejso.2019.11.503. Epub 2019 Nov 20. Eur J Surg Oncol. 2020. PMID: 31785986 No abstract available.
Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signature.
van Olmen JP, Jacobs CF, Bartels SAL, Loo CE, Sanders J, Vrancken Peeters MTFD, Drukker CA, van Duijnhoven FH, Kok M. van Olmen JP, et al. Among authors: vrancken peeters mtfd. Breast. 2024 Jun;75:103726. doi: 10.1016/j.breast.2024.103726. Epub 2024 Apr 5. Breast. 2024. PMID: 38599047 Free PMC article.
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.
van der Voort A, Louis FM, van Ramshorst MS, Kessels R, Mandjes IA, Kemper I, Agterof MJ, van der Steeg WA, Heijns JB, van Bekkum ML, Siemerink EJ, Kuijer PM, Scholten A, Wesseling J, Vrancken Peeters MTFD, Mann RM, Sonke GS; Dutch Breast Cancer Research Group. van der Voort A, et al. Among authors: vrancken peeters mtfd. Lancet Oncol. 2024 May;25(5):603-613. doi: 10.1016/S1470-2045(24)00104-9. Epub 2024 Apr 5. Lancet Oncol. 2024. PMID: 38588682 Clinical Trial.
87 results